Author

Eric C. Mossel

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

High seroprotection rates among adults 10 years after inactivated Vero cell-derived Japanese encephalitis vaccine, IXIARO

Japanese encephalitis (JE), a mosquito-borne, vaccine-preventable disease, is a risk in parts of Asia and Oceania. A previous study showed that after a primary 2-dose series and booster dose of the Vero cell-derived JE vaccine (JE-VC; IXIARO), high seroprotection rates in adults persisted through 6 years. We used ser...

S. L. Hills, S. Guagliardo, Laurie A. Housel et al. · npj Vaccines · 0 citations

Sep 2026

Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

BACKGROUND Fractional doses of yellow fever vaccines have been shown to be safe and immunogenic in randomised controlled trials in adults and children. However, little evidence still remains in children younger than 2 years. We assessed immunogenicity of one-fifth (0·1 mL) and one-half (0·25 mL) fractional doses compar...

Reena H. Doshi, Irene Lubega, Pierre Muhoza et al. · The Lancet · 0 citations